SpringerOpen Newsletter

Receive periodic news and updates relating to SpringerOpen.

Open Access Editorial

Translational medicine as a permanent glue and force of clinical medicine and public health: perspectives (1) from 2012 Sino-American symposium on clinical and translational medicine

Jiebai Zhou1, Duojiao Wu2, Xinqing Liu3, Shuoqi Yuan3, Xiaoqiu Yang3 and Xiangdong Wang12*

Author Affiliations

1 Department of Pulmonary Medicine, Fudan University School of Medicine, Zhongshan Hospital, Shanghai, China

2 Biomedical Research Center, Fudan University School of Medicine, Zhongshan Hospital, Shanghai, China

3 Center of Academicians, Shanghai, China

For all author emails, please log on.

Clinical and Translational Medicine 2012, 1:21  doi:10.1186/2001-1326-1-21

Published: 5 October 2012

Abstract

Health systems globally face challenges and opportunities in balancing quality, access, and cost, where clinical and translational medicine (CTM) should play more important and powerful roles in the identification, development and validation of solutions and strategies. Strategic collaboration can gather global strengths and resources and improve health systems, care delivery, regulations and policies. CTM-driven innovation and development has the potential to achieve step-change improvements across three dimensions. Thus, we have the reasons to believe that CTM will play even more roles in the development of new diagnostics, therapies, healthcare, and policies and SAS-CTM will become more and more important platform to obtain the latest development in CTM internationally and explore new opportunities in the international collaborations.